We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
-4.33%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$396M
AUM Growth
-$27.1M
Cap. Flow
-$6.18M
Cap. Flow %
-1.56%
Top 10 Hldgs %
47.08%
Holding
55
New
3
Increased
21
Reduced
2
Closed
2

Top Sells

Rank Stock Value
1
SYY icon
Sysco
SYY
+$7.66M
2
DIS icon
Walt Disney
DIS
+$4.95M
3
ILMN icon
Illumina
ILMN
+$1.7M
4
AAPL icon
Apple
AAPL
+$3.67K

Sector Composition

Rank Sector Weight
1 Technology 31.3%
2 Healthcare 18.53%
3 Industrials 17.55%
4 Consumer Discretionary 12.75%
5 Communication Services 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOW icon
26
Lowe's Companies
LOW
$117B
$5.84M 1.47%
28,100
NYT icon
27
New York Times
NYT
$11B
$5.66M 1.43%
137,325
+835
+0.6% +$35.1K
WMT icon
28
Walmart Inc
WMT
$820B
$5.3M 1.34%
99,345
+345
+0.3% +$18.4K
HD icon
29
Home Depot
HD
$329B
$5.27M 1.33%
17,440
+75
+0.4% +$24.1K
SYK icon
30
Stryker
SYK
$127B
$5.23M 1.32%
19,145
ADBE icon
31
Adobe
ADBE
$116B
$4.59M 1.16%
9,000
ZTS icon
32
Zoetis
ZTS
$32B
$4.32M 1.09%
24,818
TJX icon
33
TJX Companies
TJX
$149B
$3.73M 0.94%
42,000
+590
+1% +$52K
CL icon
34
Colgate-Palmolive
CL
$72.3B
$3.64M 0.92%
51,200
CSX icon
35
CSX Corp
CSX
$95B
$3.14M 0.79%
102,000
RTX icon
36
RTX Corp
RTX
$285B
$2.76M 0.7%
38,348
WIRE
37
DELISTED
Encore Wire Corp
WIRE
$2.37M 0.6%
13,000
CRSP icon
38
CRISPR Therapeutics
CRSP
$5.58B
$2.36M 0.6%
+52,100
New +$2.69M
MRK icon
39
Merck
MRK
$366B
$2.23M 0.56%
21,700
IFF icon
40
International Flavors & Fragrances
IFF
$22.4B
$2.19M 0.55%
+32,105
New +$2.35M
NET icon
41
Cloudflare
NET
$107B
$2.03M 0.51%
+32,195
New +$2.06M
XOM icon
42
ExxonMobil
XOM
$644B
$1.93M 0.49%
16,400
ILMN icon
43
Illumina
ILMN
$32.6B
$1.76M 0.44%
13,174
-10,321
-44% -$1.7M
CI icon
44
Cigna
CI
$73.7B
$1.67M 0.42%
5,841
MMM icon
45
3M
MMM
$89.9B
$1.5M 0.38%
19,136
CNI icon
46
Canadian National Railway
CNI
$76.2B
$1.45M 0.37%
13,380
+340
+3% +$39K
FTV icon
47
Fortive
FTV
$18B
$1.11M 0.28%
19,905
PFE icon
48
Pfizer
PFE
$159B
$813K 0.21%
24,500
NVDA icon
49
NVIDIA
NVDA
$5.25T
$587K 0.15%
13,500
NVO
50
Novo Nordisk
NVO
$202B
$512K 0.13%
5,630
+1,040
+23% +$91.6K

Similar funds

Chad R. Baker's Q3 2023 Portfolio in Review

As of Q3 2023, Chad R. Baker held 55 positions worth $396M, down 6.4% from $423M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Chad R. Baker's Q3 2023 filing shows 3 new, 21 increased, 2 reduced and 2 closed positions. Its largest new stake was CRISPR Therapeutics: 52,100 shares worth $2.36M. The largest sale was Sysco, an estimated $7.66M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Chad R. Baker's largest Q3 2023 buy was CRISPR Therapeutics: 52,100 shares worth $2.36M.
  • Chad R. Baker added most to Danaher in Q3 2023, an estimated $93K increase.
  • Chad R. Baker's biggest Q3 2023 reduction was Illumina, cutting an estimated $1.7M.
  • Chad R. Baker fully exited Sysco in Q3 2023, selling an estimated $7.66M.
  • Chad R. Baker's ten largest holdings make up 47% of its $396M portfolio in Q3 2023.
  • Chad R. Baker opened 3 new positions and closed 2 in Q3 2023.
  • Chad R. Baker's portfolio value fell 6.4% quarter-over-quarter to $396M.

Based on Chad R. Baker's 13F filing for Q3 2023, filed 17 Oct 2023.